BlueCrest Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-8,896	Closed	-$516K	–	808
2017 Q3	$516K	Buy	+8,896	New	+$516K	0.02%	493